Average Co-Inventor Count = 5.90
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (12 from 2,405 patents)
2. Merck + Co., Inc. (8 from 4,770 patents)
3. Merch Sharp & Dohme Ltd (1 from 4 patents)
20 patents:
1. 12344595 - 2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors
2. 12331018 - Pyrrolidine orexin receptor agonists
3. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors
4. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors
5. 8975261 - Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors
6. 8710076 - 2,5-disubstituted piperidine orexin receptor antagonists
7. 8691827 - Amino tetrahydro-pyridopyrimidine PDE10 inhibitors
8. 8669272 - 2,5-disubstituted piperidine orexin receptor antagonists
9. 8569311 - Pyridyl piperidine orexin receptor antagonists
10. 8492392 - Alkoxy tetrahydro-pyridopyrimidine PDE10 inhibitors
11. 8349830 - Aryl aminopyridine PDE10 inhibitors
12. 7951797 - Substituted diazepan orexin receptor antagonists
13. 7745639 - Mitotic kinesin inhibitors
14. 7595337 - Mitotic kinesin inhibitors
15. 7235580 - Mitotic kinesin inhibitors